Vitiligo in Children: What’s New in Treatment?

  • Serena Gianfaldoni University G. Marconi of Rome - Dermatology and Venereology, University G. Marconi of Rome, Rome
  • Georgi Tchernev Medical Institute of Ministry of Interior Department of General, Vascular and Abdominal Surgery, Sofia; Onkoderma - Policlinic for Dermatology and Dermatologic Surgery, Sofia
  • Uwe Wollina Städtisches Klinikum Dresden, Department of Dermatology and Allergology, 01067 Dresden
  • Jacopo Lotti University G. Marconi of Rome - Dept. of Nuclear, Subnuclear and Radiation Physics, Rome
  • Miriam Rovesti Department of Dermatology, University of Parma, Parma
  • Francesca Satolli Department of Dermatology, University of Parma, Parma
  • Katlein França University of Miami School of Medicine, Miami, Florida, United States and Centro Studi per la Ricerca Multidisciplinare e Rigenerativa, Università Degli Studi "G. Marconi”, Rome
  • Torello Lotti University G. Marconi of Rome, Dermatology and Venereology, Rome
Keywords: Childhood vitiligo, Innovative treatments, Excimer laser, Micro-focused phototherapy, UVA-1 laser, selective sunlight therapy, Immunomodulatory agent, Antioxidants, Low dose medicine, Dead Sea Climatotherapy

Abstract

Vitiligo is an acquired chronic hypopigmentary disorder, which usually stars in childhood. The Authors discuss a short review of the more innovative therapies for childhood vitiligo.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Kanwar AJ, Kumaran MS. Childhood Vitiligo: Treatment Paradigms. Indian J Dermatol. 2012; 57(6): 466–474. https://doi.org/10.4103/0019-5154.103067 PMid:23248365 PMCid:PMC3519254

Kandaswamy S, Akhtar N, Ravindran S, et Al. Phototherapy in Vitiligo: Assessing the compliance, Response and Patient's Perception about Disease and Treatment. Indian J Dermatol. 2013; 58(4):325. https://doi.org/10.4103/0019-5154.113944 PMid:23919018 PMCid:PMC3726895

Lotti TM, Berti SF, Hercogova J, et Al. Vitiligo: recent insights and new therapeutic approaches.G Ital Dermatol Venereol. 2012; 147(6):637-47. PMid:23149710

Krüger C, Smythe JW, Spencer JD, et Al. Significant immediate and long-term improvement in quality of life and disease coping in patients with vitiligo after group climatotherapy at the Dead Sea. Acta Derm Venereol. 2011; 91(2):152-9. https://doi.org/10.2340/00015555-1037 PMid:21240455

Schallreuter KU, Moore J, Behrens-Williams S, et al. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol. 2002; 41(8):482-7. https://doi.org/10.1046/j.1365-4362.2002.01463.x PMid:12207762

Patel DC, Evans AV, Hawk JL. Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin Exp Dermatol. 2002; 27(8):641-4. https://doi.org/10.1046/j.1365-2230.2002.01142.x PMid:12472535

Naini FF, Shooshtari AV, Ebrahimi B, Molaei R. The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study. J Res Pharm Pract. 2013; 1(2):77-80.

Bakis - Petsoglou S, Le Guay JL, Wittal R. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo. Br J Dermatol. 2009; 161(4):910-7. https://doi.org/10.1111/j.1365-2133.2009.09252.x PMid:19523170

McCoy J, Goren A, Lotti T. In vitro evaluation of a novel topical cream for vitiligo and psoriasis that selectively delivers NB-UVB therapy when exposed to sunlight. Dermatol Ther. 2014; 27(2):117-20. https://doi.org/10.1111/dth.12079 PMid:23952638

Goren A, Salafia A, McCoy J, Keene S, Lotti T. Novel topical cream delivers safe and effective sunlight therapy for vitiligo by selectively filtering damaging ultraviolet radiation. Dermatol Ther. 2014; 27(4):195-7. https://doi.org/10.1111/dth.12115 PMid:24548413

Lotti T, Buggiani G, Troiano M et Al. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Dermatol Ther. 2008; 21(Suppl 1):S20-6. https://doi.org/10.1111/j.1529-8019.2008.00198.x PMid:18727812

Ostovari N, Passeron T, Zakaria W, et al. Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response. Lasers Surg Med. 2004; 35:152-6. https://doi.org/10.1002/lsm.20057 PMid:15334620

Mehraban S, Feily A. 308nm Excimer Laser in Dermatology. J Lasers Med Sci. 2014; 5(1):8-12. PMid:25606333 PMCid:PMC4290518

Gianfaldoni S, Zarrab Z, Lotti T. Phototherapy and Vitiligo Re-pigmentation: From PUVA to Micro- focused Phototherapy. Journal of Pigmentary Disorders. 2014; 1:102.

Gianfaldoni S, Hercogova J, Lotti T. The last frontier of Vitiligo repigmentation. The Asthetic J. 2014;34-37.

Gianfaldoni S, Zanardelli M, Lotti. Vitiligo repigmentation: what's new? J Dermatolog Clin Res. 2014; 2(3):1023.

Lotti TM, Hercogova J, D'Erme AM et Al. UVA-1 in dermatology: clinical studies and observations. In UVA1 in dermatology. Evidence, data, hypotheses. Nuova Prhomos Publishing House Italy, 2013:74-160.

Lotti TM, Hercogova J, D'Erme AM et Al. UVA -1 Light vs UVA -1 Laser emission Devices. In UVA1 in dermatology. Evidence, data, hypotheses. Nuova Prhomos Publishing House Italy, 2013:68-71.

Korobko IV, Lomonosov KM. Acridone acetic acid, sodium salt, as an agent to stop vitiligo progression: a pilot study. Dermatol Ther. 2014; 27(4):219-22. https://doi.org/10.1111/dth.12121 PMid:24548590

Ramaiah A, Kar HK, Garg VK, Bajaj N, Gupta L. A Double Blind Randomized Phase IV Clinical Trial of basic Fibroblast Growth Factor Related Deca-peptide in Vitiligo. Pigmentary Disorders S. 2015; 3:S3-004.

Westerhof W, d'Ischia M. Pigment Cell Res. 2007; 20:345–359.

PMid:17850508

Prignano F, Pescitelli L, Becatti M, et al. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. J Dermatol Sci. 2009; 54:157–67. https://doi.org/10.1016/j.jdermsci.2009.02.004 PMid:19282153

Lotti T, Turini D, Hercogova J. Natural Antioxidants in general dermatology. World Health Academy Ediction, 2013.

Lotti T, Hercogova J, Wollina U, et Al. Treating skin diseases according to the low dose medicine principles. Data and hypotheses. J Biol Regul Homeost Agents. 2015; 29(1 Suppl):47-51. PMid:26016968

Lotti T, Hercogova J, Wollina U, et Al. Vitiligo: successful combination treatment based on oral low dose cytokines and different topical treatments. J Biol Regul Homeost Agents. 2015; 29(Suppl 1):53-8. PMid:26016984

Published
2018-01-21
How to Cite
1.
Gianfaldoni S, Tchernev G, Wollina U, Lotti J, Rovesti M, Satolli F, França K, Lotti T. Vitiligo in Children: What’s New in Treatment?. Open Access Maced J Med Sci [Internet]. 2018Jan.21 [cited 2020Oct.22];6(1):221-5. Available from: https://www.id-press.eu/mjms/article/view/oamjms.2018.060

Most read articles by the same author(s)

1 2 3 > >>